NPCE Live signals | Maximize Profits with Getagraph.com

BUY 129072 min ago

@ $16.08

Issued: 12 Feb 2024 @ 09:30

Return: -47.14%

Live Chart Being Loaded With Signals

Commentary (10 May 2024 @ 16:00):

Stats
Today's Volume	308 222
Average Volume	118 449
Market Cap	244.12M
EPS	$0 ( 2024-05-08 )
Next earnings date	( $0 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.69
ATR14	$0.0340 (0.40%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Orbimed Advisors Llc	Sell	15 690	Common Stock
2024-05-02	Orbimed Advisors Llc	Sell	8 842	Common Stock
2024-05-03	Orbimed Advisors Llc	Sell	4 674	Common Stock
2024-04-24	Orbimed Advisors Llc	Sell	1 781	Common Stock
2024-04-19	Orbimed Advisors Llc	Sell	18 253	Common Stock

INSIDER POWER
14.82
Last 97 transactions
Buy: 3 318 075 \| Sell: 1 148 594

Volume Correlation

Long: 0.06 (neutral)

Short: -0.82 (strong negative)

Signal:(47.259) Neutral

NeuroPace, Inc. Correlation

10 Most Positive Correlations
ICCM	0.892
RBKB	0.891
PROV	0.891
ISTR	0.889
FCRD	0.889
CPLP	0.889
NSTS	0.88
ALTR	0.875
WTFCM	0.87
WLTW	0.859

10 Most Negative Correlations
MLVF	-0.88
PFBI	-0.868
ADN	-0.862
RMRM	-0.861
XPDI	-0.856
BJDX	-0.85
CNSP	-0.847
BFRI	-0.844
KC	-0.843
RIBT	-0.837

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NeuroPace, Inc. Correlation - Currency/Commodity

0.02
( neutral )

0.16
( neutral )

0.00
( neutral )

-0.09
( neutral )

-0.05
( neutral )

NeuroPace, Inc. Financials

Annual	2023
Revenue:	$65.42M
Gross Profit:	$48.12M (73.56 %)
EPS:	$-1.270

FY	2023
Revenue:	$65.42M
Gross Profit:	$48.12M (73.56 %)
EPS:	$-1.270

FY	2022
Revenue:	$45.52M
Gross Profit:	$32.49M (71.38 %)
EPS:	$-2.17

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.497

Financial Reports:

No articles found.

NeuroPace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.